Tag: Featured

Researchers from Denmark have explored perceptions of pregnant women regarding medication use during pregnancy. More information can be found here. Photo by bruce mars on Unsplash

Pregnancy labelling of medications is a hotly debated issue in the field of teratology, and several studies have shown the limitations of providing pregnancy safety category ratings for medicines. In this recent academic highlights article, the authors summarise discussions which were held at an April 2017 meeting focussed on pregnancy pharmacogivilance and the FDAs pregnancy and lactation labelling rule. Further […]

Researchers from Boston have reviewed the important methodological considerations regarding the use of large healthcare utilization databases for drug safety surveillance in pregnancy. More information can be found here.   Photo by Hans-Peter Gauster on Unsplash

Researchers from Lyon have updated the 1995 meta-analysis of neural tube defect risk following clomiphene use which found a non-significant increased risk. More information can be found here.

A collaborative of researchers from the Botswana Harvard AIDS Institute Partnership have published their findings from a study into infant neurodevelopment following maternal use of efavirenz in pregnancy. More information can be found here.   Image by mmmCCC from Pixabay

A new study has been published which reports the outcomes of pregnancies exposed to teriflunomide occurring inadvertently in clinical trials and as observed through post-marketing surveillance. Further information can be found here.   Photo by rawpixel on Unsplash

Data from the international EURAP registry has been utilised to provide a comparison of the malformation risks for carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, topiramate, and valproate. Further information can be found here.   Photo by rawpixel on Unsplash

Researchers from the Antiretroviral Pregnancy Registry and European Pregnancy and Paediatric HIV Cohort Collaboration have jointly published data from their respective registries detailing the fetal outcomes of more than 300 dolutegravir exposed pregnancies. More information can be found here.

A collaboration of researchers from the University of Washington School of Medicine and the Washington Center for Epidemiology and Environmental Health have published their findings of a review into the developmental toxicity risks for medicines included on the WHO’s Essential Medicines List. The authors described a large proportion of these medicines had limited data concerning developmental risks, identifying a clear need […]